Joseph R. Francica
National Institutes of Health(US)AstraZeneca (Netherlands)(NL)National Institute of Allergy and Infectious Diseases(US)AstraZeneca (Poland)(PL)AstraZeneca (United States)(US)
Publications by Year
Research Areas
HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, Malaria Research and Control, Mosquito-borne diseases and control, Immunotherapy and Immune Responses
Most-Cited Works
- → Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates(2020)1,152 cited
- → In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity(2015)432 cited
- → Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein(2009)336 cited
- → Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens(2020)327 cited
- → Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates(2021)323 cited
- → A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite(2018)306 cited